Table 1. Demographics and Baseline Characteristics of the Study Participants^a.

Variables	Albumin	Starch	P Values
Gender, m/f	21/9	17/13	.36
Age	66.07 ± 8.82	61.85 ± 9.10	.75
EF	38.51 ± 10.81	36.5 ± 10.99	.49
Cr-start	0.96 ± 0.18	0.88 ± 0.15	.56
Hb-start	13.16 ± 2.00	13.52 ± 1.28	.83
Graft count	4.15 ± 0.60	4.33 ± 0.763	.29
Pomp time	109.33 ± 16.28	112.39 ± 13.25	.42
Clamp time	67.89 ± 12.68	70.61 ± 10.60	.37
Trans-PC	2.89 ± 1.64	3.24 ± 1.52	.392
Trans-FFP	0.7 ± 1.38	0.91 ± 1.75	.623
Trans-Plt	3.52 ± 4.09	2.36 ± 4.18	.288
RISK factors
T2D	15	12	.137
HLP	10	8	.282
HTN	17	16	.262
COPD	1	1	.885
CVA	1	0	.265
Recent MI	9	13	.628
smoker	6	3	.156

Abbreviations: COPD, chronic obstructie polmunary disease; Cr, creatinine; CVA, cerebrovascular accidents; Hb, hemoglubine; HLP, hyperlipidemia; MI, myocardial infarction; Trans-FFP, transfused units of fresh frozen plasma; Trans-PC, transfused units of packed cells; Trans-Plt, transfused units of platlets; T2D, type 2 diabetes; HTN, hypertension.

^aP values were calculated using Chi-squared test, Fisher’s exact test, independent t-test or Mann-Whitney U test, as appropriate.